| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.38 | 0.2 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.34 | 0.3 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.3 | 0.3 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.01 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.17 | 0.04 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.05 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.15 | 0.02 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.06 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.13 | 0.09 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |